| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | TAE684 | CCLE | pan-cancer | AAC | 0.18 | 3e-05 |
| mRNA | Crizotinib | CCLE | pan-cancer | AAC | 0.1 | 0.02 |
| mRNA | Nilotinib | CCLE | pan-cancer | AAC | -0.085 | 0.08 |
| mRNA | Irinotecan | CCLE | pan-cancer | AAC | 0.083 | 0.1 |
| mRNA | TKI258 | CCLE | pan-cancer | AAC | -0.062 | 0.2 |
| mRNA | Nutlin-3 | CCLE | pan-cancer | AAC | 0.062 | 0.2 |
| mRNA | AEW541 | CCLE | pan-cancer | AAC | -0.06 | 0.2 |
| mRNA | AZD0530 | CCLE | pan-cancer | AAC | -0.05 | 0.3 |
| mRNA | Panobinostat | CCLE | pan-cancer | AAC | -0.041 | 0.3 |
| mRNA | PHA-665752 | CCLE | pan-cancer | AAC | 0.041 | 0.4 |